Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 10:47 PM
Ignite Modification Date:
2025-12-24 @ 10:47 PM
NCT ID:
NCT05613569
Eligibility Criteria:
Inclusion Criteria :
To be considered eligible to participate in this study, a patient must meet the inclusion criteria listed below:
1. Patients that have completed the KS-GIG-001-01 Study and were in the Active Treatment group
2. Patients having signed the consent forms for both the KS-GIG-001-01 Study and this Long Term, 3-Year Follow-up Study
Exclusion Criteria :
To be eligible for entry into the study, the patient must not meet any of the exclusion criteria listed below:
1\. Enrollment in another AAV or other gene therapy trial
Healthy Volunteers:
False
Sex:
ALL
Study:
NCT05613569
Study Brief:
Protocol Section:
NCT05613569